Ignite Creation Date:
2025-12-24 @ 2:33 PM
Ignite Modification Date:
2026-01-15 @ 6:02 PM
Study NCT ID:
NCT05756959
Status:
RECRUITING
Last Update Posted:
2023-03-09
First Post:
2023-02-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Myopia Control Combined PBM With Myopic Defocus Lens in Children
Sponsor:
Beijing Airdoc Technology Co., Ltd.
Organization:
Study Overview
Official Title:
Myopia Control Combined PBM With Myopic Defocus Lens in Children: Double-blind RCT for 6 Month
Status:
RECRUITING
Status Verified Date:
2023-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To study the efficacy of myopi control with two methods: low lever red light and peripheral defocus spectacles with four groups and design with prospective, double-blind, randimized, and with control for 6 month.
Detailed Description:
myopic children with age from 6 \~13 years old. And refraction from -0.50D\~-5.50D.
The red light is low lever laser therapy at wavelength of 650nm.
The red light is low lever laser therapy at wavelength of 650nm.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: